FIELD: biotechnology.
SUBSTANCE: recombinant plasmid DNA pGEM-Puro-DS-Apo is proposed comprising synthetic apoptin gene flanked by sequences of vaccinia virus genome of island C10L-C12L, and the recombinant strain VVdGF-ApoS24/2 of vaccinia virus producing apoptin.
EFFECT: invention can be used to develop medicinal products to control cancerous diseases.
2 cl, 5 dwg, 1 tbl, 6 ex
Authors
Dates
2013-09-10—Published
2012-08-20—Filed